Latest News
Conference Coverage
MedPAC: Medicare Part B drug payment cuts, shared savings could save $5 billion
Reducing the amount physicians are paid for drugs administered in their offices and introducing shared savings could save Medicare up to $5...
From the Journals
Secukinumab beat etanercept in 52-week psoriasis quality of life analysis
Secukinumab was associated with faster and greater improvements in self-reported quality of life in psoriasis patients, compared with etanercept...
Conference Coverage
Evidence for medical marijuana largely up in smoke
SAN DIEGO – Despite the popularity of medical marijuana, robust evidence for its use is limited or nonexistent for most medical conditions.
News
FDA approves first home genetic health risk test
Consumers do seem to want to know.
From the Journals
Fatigue in rheumatoid arthritis declines with pedometer use
Rheumatoid arthritis patients increased the number of steps they walked and decreased their fatigue levels when given pedometers over a 21-week...
Conference Coverage
Belimumab response at 2 years achieved by two-thirds of lupus patients
MELBOURNE – Patients with greater disease activity and polyarthritis were the most likely to respond to treatment.
From the Journals
Stopping TNF inhibitors for pregnancy may invite flares
Prospective study of 75 patients with rheumatoid arthritis and 61 with axial spondyloarthritis also looked at response after resuming TNF...
Conference Coverage
What’s old is new in topical psoriasis therapy
WAILEA, HAWAII – Fixed-combination halobetasol/tazarotene lotion proves safe and effective in phase II study.
Conference Coverage
Incorporate steroid dose into lupus disease activity score, expert says
MELBOURNE – A new index that uses glucocorticoid dose might better account for organ damage.
Conference Coverage
Lupus nephritis expert offers management tips
MELBOURNE – Dr. Frédéric Houssiau gives advice on comorbidity management and induction therapy in lupus nephritis, among other things.
From the Journals
First treat-to-target gout trial supports allopurinol dose escalation
Gradually ramping up the dose of allopurinol to achieve target serum urate levels in gout patients who tolerate the drug is safe and effective,...